Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Drug Development

      CURE Pharmaceutical Secures Patent on Oral Thin Films With Bi-Phasic Release of Natural Ingredients

      Manufacturing
      CURE Pharmaceutical, an innovative drug delivery and development company, announced the allowance of U.S. Application No. 15/666,057, which covers edible thin films with natural...

      Boehringer Ingelheim Expands IPF Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics

      News
      Boehringer Ingelheim and Bridge Biotherapeutics Inc. announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge...

      Sernova Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data

      Clinical Trials
      Sernova Corp, a clinical-stage regenerative medicine company announced that its human Phase I/II clinical trial for type-1 diabetes is advancing with additional patients for...

      Orphazyme completes enrollment in phase 3 trial evaluating arimoclomol in amyotrophic lateral sclerosis

      Clinical Trials
      Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases announces that it has completed enrollment in its phase...

      Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain

      Manufacturing
      Cryoport, Inc and EVERSANA have announced a strategic alliance to further create a fully integrated regenerative medicine supply chain solution. The alliance will be...

      Hilleman Laboratories licenses Oral Cholera Vaccine Hillchol to Bharat Biotech

      Drug Development
      Hilleman Laboratories, a global research and development organization focused on delivering high-impact and affordable vaccines, announced that it has entered into a collaboration with...

      IBM KPMG Merck and Walmart to collaborate as part of FDA s program to evaluate the use of blockchain to protect pharmaceutical product integrity

      FDA Approvals
      IBM and Walmart  announced that the companies have been selected by the US FDA to be included in a program in support of the...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.